Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

Right Now

Automated Breast Ultrasound Systems (ABUS) Market: Competitive Analysis, Market Trends and Forecast to 2031

Market Overview and Report Coverage

Automated Breast Ultrasound Systems (ABUS) are advanced imaging devices designed for the screening and detection of breast cancer. These systems use automated technology to capture images of the breast tissue, providing a detailed and accurate assessment of any abnormalities or potential tumors.

The future outlook of the ABUS market is promising, with a projected growth rate of % during the forecasted period. The increasing incidence of breast cancer, rising awareness about the importance of early detection, and technological advancements in imaging systems are driving the growth of the ABUS market.

The current market outlook shows a growing demand for ABUS systems, as healthcare providers are increasingly adopting these devices for their efficiency and accuracy in detecting breast cancer. The market forecast indicates a steady growth trajectory for ABUS systems, with continuous developments in imaging technology and improvements in diagnostic accuracy.

Some of the latest market trends in the ABUS industry include the integration of artificial intelligence and machine learning algorithms for more precise and automated image analysis, as well as the development of portable and user-friendly ABUS systems for increased accessibility in healthcare settings. Overall, the ABUS market is poised for substantial growth and innovation in the coming years.

Get a Sample PDF of the Report:


Market Segmentation

The Automated Breast Ultrasound Systems (ABUS) Market Analysis by types is segmented into:

  • Automated Breast Ultrasound Systems(ABUS)
  • Automated Breast Volume Scanner (ABVS)


Automated Breast Ultrasound Systems (ABUS) and Automated Breast Volume Scanner (ABVS) are advanced technologies used for breast imaging to detect breast cancer in women. ABUS utilizes automated ultrasound technology to create detailed 3D images of the breast, providing a more comprehensive screening compared to traditional mammograms. ABVS, on the other hand, offers a more efficient and accurate way to scan the entire breast volume. Both systems are gaining popularity in the market for their improved capabilities in early detection and diagnosis of breast cancer.

Get a Sample PDF of the Report:


The Automated Breast Ultrasound Systems (ABUS) Market Industry Research by Application is segmented into:

  • Hosptials
  • Diagnostic Imaging Centers
  • Others


Automated Breast Ultrasound Systems (ABUS) are increasingly being used in hospitals, diagnostic imaging centers, and other medical facilities for breast cancer screening and detection. ABUS provides a more detailed and accurate assessment of breast tissue compared to traditional mammograms, particularly in women with dense breast tissue. This technology is particularly beneficial for patients who have an increased risk of developing breast cancer or those who have difficulty undergoing traditional imaging methods.

Purchase this Report:


In terms of Region, the Automated Breast Ultrasound Systems (ABUS) Market Players available by Region are:

North America:

  • United States

  • Canada


  • Germany

  • France

  • U.K.

  • Italy

  • Russia


  • China

  • Japan

  • South Korea

  • India

  • Australia

  • China Taiwan

  • Indonesia

  • Thailand

  • Malaysia

Latin America:

  • Mexico

  • Brazil

  • Argentina Korea

  • Colombia

Middle East & Africa:

  • Turkey

  • Saudi

  • Arabia

  • UAE

  • Korea

What are the Emerging Trends in the Global Automated Breast Ultrasound Systems (ABUS) market?

Emerging trends in the global Automated Breast Ultrasound Systems (ABUS) market include the increasing adoption of 3D ABUS technology for higher accuracy in breast cancer detection, as well as the development of portable and handheld ABUS devices for improved accessibility in remote areas. Current trends in the market focus on the integration of artificial intelligence and machine learning algorithms for automated image analysis, as well as the growing demand for personalized, patient-centric ABUS solutions. Additionally, advancements in software technology are enabling enhancements in image quality and interpretation, driving the growth of the ABUS market worldwide.

Inquire or Share Your Questions If Any Before Purchasing This Report-


Major Market Players

GE Healthcare is a key player in the Automated Breast Ultrasound Systems (ABUS) market, offering innovative solutions for the early detection of breast cancer. The company has a strong presence in the market, with a wide product portfolio and global distribution network. GE Healthcare has been focusing on developing advanced imaging technologies to improve the accuracy and efficiency of breast cancer diagnosis.

Siemens is another major player in the ABUS market, known for its high-quality imaging systems and comprehensive solutions for breast cancer screening. The company has been investing heavily in research and development to introduce new products and technologies to meet the evolving needs of healthcare providers and patients. Siemens has a strong customer base and a solid reputation in the market.

Koninklijke Philips . is also a prominent player in the ABUS market, offering cutting-edge imaging solutions for breast cancer detection and diagnosis. The company has been expanding its product range and market presence through strategic partnerships and acquisitions. Koninklijke Philips N.V. has a strong focus on innovation and customer satisfaction, which has helped it maintain a leading position in the ABUS market.

The global ABUS market is expected to witness significant growth in the coming years, driven by increasing awareness about breast cancer screening and the growing demand for advanced imaging technologies. The market size is projected to reach billions of dollars by 2027, with key players such as GE Healthcare, Siemens, and Koninklijke Philips N.V. expected to continue dominating the market.

Sales revenue for these companies varies, with GE Healthcare reporting annual sales revenue of several billion dollars, while Siemens and Koninklijke Philips N.V. also generating substantial revenue from their ABUS products and services. These companies are expected to continue expanding their market share and revenue through product innovation and strategic partnerships in the ABUS market.

Purchase this Report:

Check more reports on

More Posts

Load More wait